Fangfang Yan

6PUBLICATIONS
13CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Epigenetics (incl. genome methylation and epigenomics)Molecular targetsGenome structure and regulation
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 09, 2026
Reversible and irreversible BTK inhibition promotes stem-like functional multipotency, persistence, and antitumor efficacy of CD19-directed CAR T cells in mantle cell lymphoma.

|Jan 27, 2024
Single-cell multiomics decodes regulatory programs for mouse secondary palate development.

Fangfang Yan, Akiko Suzuki, Chihiro Iwaya

|Nov 03, 2023
Potentiation of apoptosis in drug-resistant mantle cell lymphoma cells by MCL-1 inhibitor involves downregulation of inhibitor of apoptosis proteins.

Yijing Li, Heng-Huan Lee, Vivian Changying Jiang

|May 31, 2023
Dual targeting of CDK4/6 and Bcl-2 exhibits a potent antitumor effect on mantle cell lymphoma.

Yuxuan Che, Yang Liu, Yijing Li

|Jul 01, 2022
Spatiotemporal MicroRNA-Gene Expression Network Related to Orofacial Clefts.

F Yan, L M Simon, A Suzuki

|Nov 25, 2020
A developmental stage-specific network approach for studying dynamic co-regulation of transcription factors and microRNAs during craniofacial development.

Fangfang Yan, Peilin Jia, Hiroki Yoshioka

Pageof 1

Frequent Collaborators

3 joint publications

Junichi Iwata

3 joint publications

Zhongming Zhao

3 joint publications

Yang Liu

3 joint publications

Michael Wang